MX2009006808A - Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico. - Google Patents
Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico.Info
- Publication number
- MX2009006808A MX2009006808A MX2009006808A MX2009006808A MX2009006808A MX 2009006808 A MX2009006808 A MX 2009006808A MX 2009006808 A MX2009006808 A MX 2009006808A MX 2009006808 A MX2009006808 A MX 2009006808A MX 2009006808 A MX2009006808 A MX 2009006808A
- Authority
- MX
- Mexico
- Prior art keywords
- lactic acid
- methicillin
- staphylococcus aureus
- resistant staphylococcus
- growth inhibition
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title abstract 10
- 241000894006 Bacteria Species 0.000 title abstract 5
- 235000014655 lactic acid Nutrition 0.000 title abstract 5
- 239000004310 lactic acid Substances 0.000 title abstract 5
- RJQXTJLFIWVMTO-TYNCELHUSA-N Methicillin Chemical compound COC1=CC=CC(OC)=C1C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 RJQXTJLFIWVMTO-TYNCELHUSA-N 0.000 title abstract 4
- 241000191967 Staphylococcus aureus Species 0.000 title abstract 4
- 229960003085 meticillin Drugs 0.000 title abstract 4
- 230000009036 growth inhibition Effects 0.000 title abstract 2
- 230000008030 elimination Effects 0.000 title 1
- 238000003379 elimination reaction Methods 0.000 title 1
- 241000186660 Lactobacillus Species 0.000 abstract 1
- 240000001046 Lactobacillus acidophilus Species 0.000 abstract 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 229940039696 lactobacillus Drugs 0.000 abstract 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/20—Bacteria; Substances produced thereby or obtained therefrom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
- A23C11/103—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins containing only proteins from pulses, oilseeds or nuts, e.g. nut milk
- A23C11/106—Addition of, or treatment with, microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
- A23L11/65—Soy drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/23—Lactobacillus acidophilus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
- C12R2001/245—Lactobacillus casei
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Agronomy & Crop Science (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- Pest Control & Pesticides (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Botany (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
Abstract
La presente invenci?n se refiere a la inhibici?n del crecimiento del Estafilococo Aureus resistente a la meticilina mediante hebras de bacterias del ?cido l?ctico. M?s espec?ficamente se dirige al uso de hebras de bacterias del ?cido l?ctico, composiciones que comprenden hebras de las bacterias del ?cido l?ctico, m?todos de uso y equipos de los mismos para inhibir el crecimiento del Estafilococo Aureus resistencia a la meticilina. Esta invenci?n se refiere m?s espec?ficamente al efecto inhibidor de las hebras de las bacterias del ?cido l?ctico Lactobacilos acidophilus y Lactobacilos casei del Estafilococo aureus resistente a la meticilina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87646006P | 2006-12-22 | 2006-12-22 | |
| PCT/CA2007/002348 WO2008077251A1 (en) | 2006-12-22 | 2007-12-21 | Growth inhibition and elimination of methicillin-resistant staphylococcus aureus by lactic acid bacteria |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009006808A true MX2009006808A (es) | 2010-04-01 |
Family
ID=39562057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009006808A MX2009006808A (es) | 2006-12-22 | 2007-12-21 | Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8926960B2 (es) |
| EP (1) | EP2124976B1 (es) |
| AT (1) | ATE526027T1 (es) |
| CA (1) | CA2673195C (es) |
| ES (1) | ES2373411T3 (es) |
| MX (1) | MX2009006808A (es) |
| WO (1) | WO2008077251A1 (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120276149A1 (en) * | 2009-10-15 | 2012-11-01 | Dan Littman | Methods for modulating bacterial infection |
| RU2015148488A (ru) | 2013-04-23 | 2017-05-25 | Терраджен Холдингз Лимитед | Обладающие противомикробной активностью бактериальные штаммы и содержащие их композиции для биоконтроля |
| CZ201523A3 (cs) | 2015-01-16 | 2016-07-27 | Bio Agens Research And Development - Bard, S.R.O. | Duální mikrobiální preparát pro dlouhodobé potlačení nebo prevenci symptomů oportunních mikrobiálních infekcí |
| CA3084954A1 (en) | 2017-12-05 | 2019-06-13 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| CZ201975A3 (cs) | 2019-02-11 | 2020-03-11 | BiomCare s.r.o. | Kombinované několikastupňové mikrobiální přípravky a způsob jejich aplikace |
| CN111979292B (zh) * | 2020-07-27 | 2022-08-05 | 广东省微生物研究所(广东省微生物分析检测中心) | 一种同时携带多重耐药基因cfr和lsa(E)的MRSA的用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE355360T1 (de) | 1996-11-29 | 2006-03-15 | Bio K & Internat Inc | Milchsaüreferment das ein spezieller stamm von lactobacillus acidophilus enthältund verwendung |
| ATE496989T1 (de) * | 1997-02-11 | 2011-02-15 | Entpr Ie Trd As Bioresearch Ie | Probiotische stämme des lactobacillus salivarius und daraus hergestellte antimikrobielle mittel |
| ITMO20020001A1 (it) * | 2002-01-04 | 2003-07-04 | Giuliano Zanaglia | Lactobacillo per la preservazione di prodotti vegetali di iv gamma, loro miscele, derivati di prodotti vegetali di iv gamma e loro miscele |
-
2007
- 2007-12-21 MX MX2009006808A patent/MX2009006808A/es active IP Right Grant
- 2007-12-21 AT AT07855628T patent/ATE526027T1/de not_active IP Right Cessation
- 2007-12-21 CA CA2673195A patent/CA2673195C/en active Active
- 2007-12-21 WO PCT/CA2007/002348 patent/WO2008077251A1/en not_active Ceased
- 2007-12-21 ES ES07855628T patent/ES2373411T3/es active Active
- 2007-12-21 EP EP07855628A patent/EP2124976B1/en active Active
-
2010
- 2010-06-14 US US12/814,661 patent/US8926960B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CA2673195A1 (en) | 2008-07-03 |
| WO2008077251A1 (en) | 2008-07-03 |
| EP2124976A4 (en) | 2010-05-12 |
| US8926960B2 (en) | 2015-01-06 |
| ATE526027T1 (de) | 2011-10-15 |
| ES2373411T3 (es) | 2012-02-03 |
| CA2673195C (en) | 2012-05-29 |
| EP2124976B1 (en) | 2011-09-28 |
| US20110195057A1 (en) | 2011-08-11 |
| EP2124976A1 (en) | 2009-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008111719A8 (en) | Bacillus amyloliquefaciens k317 for suppressing the growth of antibiotics-resistant pathogenic microorganism or enteropathogenic microorganism | |
| WO2007130655A3 (en) | Phage derived antimicrobial activities | |
| WO2009102143A3 (ko) | 김치유래 락토바실러스 플란타룸 bls41 및 그 용도 | |
| EP3409666A3 (en) | Seca inhibitors and methods of making and using thereof | |
| NZ591051A (en) | C7-fluoro substituted tetracycline compounds | |
| RU2010129158A (ru) | Способ очистки мерзлотных почв от нефти спорообразующими бактериями bacillus subtilis | |
| WO2011163500A3 (en) | Methods and compositions for reducing body odor | |
| WO2012003474A3 (en) | Compositions and methods related to protein a (spa) variants | |
| PH12016502092A1 (en) | Antimicrobial compounds and methods of making and using the same | |
| WO2010090860A3 (en) | Methods and compositions for treating bacterial infection | |
| UA109876C2 (uk) | Композиція, що містить bifidobacterium longum cncm i-2618, для лікування та профілактики імунних розладів | |
| WO2015100331A3 (en) | Phenazine derivatives as antimicrobial agents | |
| WO2010063996A3 (en) | Antibacterial compounds | |
| PH12015502416A1 (en) | Bacterial strains having antimicrobial activity and biocontrol compositions comprising the same | |
| WO2010064930A8 (en) | Use of lactic acid bacteria to treat or prevent eczema | |
| MY176900A (en) | Antimicrobial compounds and methods of making and using the same | |
| MX2009006808A (es) | Eliminacion e inhibicion del crecimiento del estafilococo aureus resistente a la meticilina mediante bacterias del acido lactico. | |
| AU2010306647A8 (en) | Antimicrobial compounds and methods of making and using the same | |
| MX2011008043A (es) | Derivados de actagardina. | |
| MX356959B (es) | Cepa paenibacillus alvei ts-15 y su uso en el control de organismos patogenicos. | |
| MX2021001564A (es) | Diazabiciclooctanonas como inhibidores de serina beta-lactamasas. | |
| EP1946760A4 (en) | COMPOSITION FOR IMPROVING INTESTINAL FLORA | |
| MY165011A (en) | Antimicrobial compounds and methods of making and using the same | |
| EP3939599A3 (en) | Silicate containing compositions and methods of treatment | |
| WO2008077229A8 (en) | Growth inhibition of microorganisms by lactic acid bacteria |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |